Quick Answer
Anixa Biosciences Inc reported Common Stock Shares Outstanding of 33.01 million shares for the year ending 2025.
- Anixa Biosciences Inc showed an increase of +2.5% in Common Stock Shares Outstanding from 2024 to 2025.
- This data is from Anixa Biosciences Inc's annual report (Form 10-K), filed with the SEC on January 12, 2026.
- XBRL data for this metric is available from 2010 to 2025 (16 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 16 years of available data (2010 to 2025), Anixa Biosciences Inc's Common Stock Shares Outstanding has declined by 78.5%.
- Historical annual values: Fiscal year 2025: 33.01 million shares | Fiscal year 2024: 32.20 million shares | Fiscal year 2023: 31.15 million shares | Fiscal year 2022: 30.91 million shares | Fiscal year 2021: 30.05 million shares | Fiscal year 2020: 24.25 million shares | Fiscal year 2019: 20.33 million shares | Fiscal year 2018: 18.91 million shares | Fiscal year 2017: 16.60 million shares | Fiscal year 2016: 8.75 million shares | Fiscal year 2015: 8.72 million shares | Fiscal year 2014: 8.79 million shares | Fiscal year 2013: 209.28 million shares | Fiscal year 2012: 184.98 million shares | Fiscal year 2011: 176.13 million shares | Fiscal year 2010: 153.74 million shares.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: